Microneedle Flu Vaccine market, By Product Type (Solid microneedle and Hollow microneedle), By Vaccine Type, By Application, By Country, and By Region - Industry Analysis, market Application, market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Microneedle Flu Vaccine Market Application was valued at USD 1,630.43 Million in 2023, expanding at a CAGR of 6.30% from 2024 to 2032.
The microneedle flu vaccine is an innovative approach to delivering influenza vaccines using microneedles, which are tiny needles typically smaller than a millimeter embedded in a small patch or device. This technology is designed to make vaccination easier, less painful, and potentially more accessible compared to traditional syringe-based methods.
Microneedle Flu Vaccine Market- Market Dynamics
Increasing demand for enhanced vaccine delivery & needle-free administration is expected to propel market demand
Microneedle flu vaccination provides enhanced immune response through intradermal delivery. Increased interest in more effective and patient-friendly vaccine technologies. Needle-free administration reduces fear and anxiety associated with traditional needle-based vaccines, increasing patient compliance, thereby boosting market growth. Also, increasing recognition of influenza\'s public health impact drives vaccine adoption. The COVID-19 pandemic highlighted the need for scalable, accessible, and efficient vaccine solutions, increasing interest in microneedle technology. Campaigns emphasizing universal immunization boost demand for innovative delivery systems.
Older adult population, particularly vulnerable to influenza, requires safer and more comfortable vaccination methods. Further, the growing preference for home healthcare solutions aligns with the self-administered nature of microneedle patches. It eliminates sharps waste, reducing environmental impact and the need for specialized disposal systems. Lowers the risk of needle-stick injuries for healthcare workers. Furthermore, microneedle systems are being used for certain applications such as drug delivery, and widespread commercial use is contributing to market growth.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MICRONEEDLE FLU VACCINE MARKET KEY PLAYERS
3M Drug Delivery Systems
Becton, Dickinson, and Company
Micron Biomedical Inc.
NanoPass Technologies
Vaxxas
Zosano Pharma Corporation
Corium, Inc.
TheraJect
Verndari, Inc.
Inovio Pharmaceuticals, Inc.
Xiamen Innovax Biotech Co., Ltd.
BioSerenTach
Transdermal Specialties, Inc.
EmulTech BV
Clearside Biomedical, Inc.
Others
GLOBAL MICRONEEDLE FLU VACCINE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032
Solid microneedle
Hollow microneedle
GLOBAL MICRONEEDLE FLU VACCINE MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019-2032
Quadrivalent flu vaccine
Trivalent flu vaccine
GLOBAL MICRONEEDLE FLU VACCINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032
Research & clinical trials
Drug delivery
Others
GLOBAL MICRONEEDLE FLU VACCINE MARKET, BY REGION- MARKET ANALYSIS, 2019-2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Microneedle Flu Vaccine Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Microneedle Flu Vaccine Market Snippet by Product Type
2.1.2. Microneedle Flu Vaccine Market Snippet by Vaccine Type
2.1.3. Microneedle Flu Vaccine Market Snippet by Application
2.1.4. Microneedle Flu Vaccine Market Snippet by Country
2.1.5. Microneedle Flu Vaccine Market Snippet by Region
2.2. Competitive Insights
3. Microneedle Flu Vaccine Key Market Trends
3.1. Microneedle Flu Vaccine Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Microneedle Flu Vaccine Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Microneedle Flu Vaccine Market Opportunities
3.4. Microneedle Flu Vaccine Market Future Trends
4. Microneedle Flu Vaccine Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Microneedle Flu Vaccine Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Microneedle Flu Vaccine Market Landscape
6.1. Microneedle Flu Vaccine Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Microneedle Flu Vaccine Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Solid microneedle
7.1.3. Hollow microneedle
8. Microneedle Flu Vaccine Market – By Vaccine Type
8.1. Overview
8.1.1. Segment Share Analysis, By Vaccine Type, 2024 & 2032 (%)
8.1.2. Quadrivalent flu vaccine
8.1.3. Trivalent flu vaccine
9. Microneedle Flu Vaccine Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
9.1.2. Research & clinical trials
9.1.3. Drug delivery
9.1.4. Others
10. Microneedle Flu Vaccine Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Microneedle Flu Vaccine Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Microneedle Flu Vaccine Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Microneedle Flu Vaccine Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Microneedle Flu Vaccine Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Microneedle Flu Vaccine Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Microneedle Flu Vaccine Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. 3M Drug Delivery Systems
11.2.2. Becton, Dickinson, and Company
11.2.3. Micron Biomedical Inc.
11.2.4. NanoPass Technologies
11.2.5. Vaxxas
11.2.6. Zosano Pharma Corporation
11.2.7. Corium, Inc.
11.2.8. TheraJect
11.2.9. Verndari, Inc.
11.2.10. Inovio Pharmaceuticals, Inc.
11.2.11. Xiamen Innovax Biotech Co., Ltd.
11.2.12. BioSerenTach
11.2.13. Transdermal Specialties, Inc.
11.2.14. EmulTech BV
11.2.15. Clearside Biomedical, Inc.
11.2.16. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
